NCT02989701View on ClinicalTrials.gov

Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 11, 2017

Study Completion Date

December 11, 2017

Conditions
Sickle Cell Disease Without Crisis
Interventions
DRUG

Plerixafor

Dose escalation of Plerixafor for Hematopoietic stem cell mobilization in patients with Sickle Cell Disease

Trial Locations (1)

02115

Boston Childrens Hospital, Boston

All Listed Sponsors
lead

Alessandra Biffi

OTHER

NCT02989701 - Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter